Editas (EDIT) Director Ellinor P. Thomas II Receives 103,400-Share Option Award

What Happened
Ellinor Patrick Thomas II, a director of Editas Medicine (EDIT), was granted a derivative award (an option) to acquire 103,400 shares on August 6, 2026. The Form 4 lists the award price as $0.00 (reflecting an option grant rather than an open‑market purchase or sale); no immediate cash transaction occurred.

Key Details

• Transaction date: August 6, 2026 (reported on Form 4 filed August 7, 2026). Filing appears timely.
• Security: Derivative (option) to acquire 103,400 shares; reported price $0.00.
• Vesting: The option vests in three equal annual installments (1/3 each) on Aug 6, 2027; Aug 6, 2028; and Aug 6, 2029 (per footnote).
• Shares owned after transaction: Not specified in the provided filing summary.
• No indication of sale or immediate exercise; this is a compensation award.

Context
This is a typical equity compensation grant to a director. Option grants vest over time and only convert to ownership if/when vested and exercised; they are not the same as an outright purchase. Such awards are common and reflect compensation practices rather than a near‑term trading signal.